Mick Hurrey

Vice President Of Pharmaceutical Development at Revagenix, Inc.

Mick Hurrey has extensive experience in pharmaceutical development, with roles ranging from Scientist I to Vice President in various companies such as Revagenix, InCarda Therapeutics, SteadyMed Therapeutics, Gilead Sciences, and Vertex Pharmaceuticals. Mick has a Ph.D. in Analytical Chemistry from the University of North Carolina at Chapel Hill and a B.S. in Chemistry from the University of Central Florida. Responsibilities have included leading CMC activities, product development, managing labs, and serving as a subject matter expert in physical chemistry.

Location

San Jose, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Revagenix, Inc.

Revagenix exists to deliver urgently needed anti-infective medicines to patients around the world.


Employees

1-10

Links